Ocular Surface and Corneal Diseases: From Cellular and Molecular Biology to Therapeutic Strategies
A special issue of Biomolecules (ISSN 2218-273X).
Deadline for manuscript submissions: 31 December 2025 | Viewed by 27
Special Issue Editors
Interests: dry eye disease; dry eye; aqueous tear deficiency; evaporative deficiency; ocu-lar surface inflammation; tear osmolarity; epidemiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We invite submissions for a Special Issue dedicated to exploring the full spectrum of ocular surface and corneal diseases, with a focus on bridging fundamental science and clinical innovation. This issue aims to highlight cutting-edge research that enhances our understanding of the cellular and molecular mechanisms underlying corneal and ocular surface pathologies, and how these insights inform novel diagnostic and therapeutic approaches.
We welcome original research articles, reviews, and translational studies addressing topics including—but not limited to—corneal immunology, wound healing, dry eye disease, limbal stem cell biology, corneal nerve regeneration, and biomaterial-based therapies. Studies employing innovative models, advanced imaging, and omics technologies are particularly encouraged.
Our goal is to foster interdisciplinary dialogue and accelerate the translation of bench discoveries into bedside interventions that improve patient outcomes. This Special Issue provides a platform for both emerging and established investigators to share their latest findings and perspectives.
Dr. Anat Galor
Dr. Pragnya Rao Donthineni
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dry eye disease
- dry eye
- aqueous tear deficiency
- evaporative deficiency
- ocular surface inflammation
- tear osmolarity
- epidemiology
- limbal stem cell deficiency
- neuropathic ocular pain
- neurotrophic keratitis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
